FDA Amends Animal Drug Regulations Due to Sponsor Name Change and Address Update

Summary

The Food and Drug Administration (FDA) is updating its animal drug regulations to reflect a name change for the sponsor from American Pharmaceutical Partners, Inc. to Abraxis Pharmaceuticals, and a change to the sponsor's mailing address.